Cocrystal Pharma Inc reports results for the quarter ended in December - Earnings Summary

Cocrystal Pharma

29/03/2023 14:03

* Cocrystal Pharma Inc  COCP.OQ  reported a quarterly
adjusted
loss of 55 cents​​ per share for the quarter ended in December.
The mean expectation of three analysts for the quarter was for a
loss of 73 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Cocrystal Pharma Inc's reported EPS for the quarter was a
loss
of 55 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Cocrystal Pharma Inc shares had fallen by 7.7% this
quarter.
    * The company reported a quarterly loss of $4.5 million.
    * Wall Street's median 12-month price target for Cocrystal
Pharma
Inc is $10.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 29 at 01:02 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.73          -0.55          Beat
 Sep. 30 2022      -0.48          -0.70          Missed
 Jun. 30 2022      -0.52          -3.00          Missed
 Mar. 31 2022      -0.42          -0.48          Missed